BSL
DXCM icon

Blue Sparrow LLC’s DexCom DXCM Stock Holding History

Blue Sparrow LLC’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.4M Buy
+480,600
New +$32M 0.31% 56

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Blue Sparrow LLC's DXCM Position: Q2 2026 in Review

Blue Sparrow LLC opened a new position in DexCom (DXCM) in Q2 2026: 480,600 shares worth $32.4M. The stake represents 0.31% of the portfolio and ranks #56 among its holdings.

966 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Blue Sparrow LLC held 480,600 shares of DexCom worth $32.4M as of Q2 2026.
  • DexCom was a new Blue Sparrow LLC position in Q2 2026.
  • DexCom made up 0.31% of Blue Sparrow LLC's portfolio in Q2 2026, its #56 holding.
  • 966 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Blue Sparrow LLC's 13F filing for Q2 2026, filed 14 Aug 2026.